drugset / Trial / NCT03868111

Sufentanil as Adjuvant of Balanced Anesthesia

NCT03868111

Completed 66 enrolled Kangbuk Samsung Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of the study was to compare the efficacy and safety between sufentanil and remifentanil as an adjuvant of balanced general anesthesia.

Timeline

Start
2019-11-04
Primary completion
2020-01-12
Completion
2020-01-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule
Subject Sufentanil Other / unclassified

Indications

No indication recorded.